Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
批准号:
311940-2006
负责人:
Burt, Helen
金额:
$2.51万
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Amphiphilic molecules, such as diblock copolymers, are macromolecules with hydrophilic and hydrophobic blocks. Other macromolecules, called dendrimers, are highly branched macromolecules will a well-defined size, capable of binding drug molecules. These polymers all form nanometre size range, spherical particles: self-associating micelles (macromolecular aggregates), vesicles (an outer membrane composed of copolymer molecules and an inner aqueous core), dendrimers (unimolecular micelles) and nanospheres (solid core particles). These so-called nano-delivery systems can all be loaded with hydrophobic drugs, such as paclitaxel, and some will accommodate hydrophilic drugs, such as cisplatin. Few studies have explored the relationship between the properties of the polymer, the type of nanoparticles formed and the performance characteristics of the nano-delivery system, such as stability, drug release, interaction with blood components, interaction with mucosal tissue surfaces and pharmacokinetics. The goal of the proposed research is to compare the delivery characteristics, blood/tissue interactions and tumor targeting of drug loaded polymeric nanosphere, vesicle, micellar and dendritic formulations following both intravenous administration, and local instillation directly into the bladder for application in the treatment of bladder cancer. Surface modification of nano-delivery systems to confer mucoadhesiveness should target the nanoparticles to bladder tumors. The research objectives are: 1) to investigate the influence of structural features of the polymers on properties and performance characteristics of the drug loaded nano-delivery systems, 2) to determine the factors influencing the interactions of untreated and surface modified nano-delivery systems with blood components and bladder tissue, 3) to evaluate the circulation lifetime, systemic uptake, pharmacokinetics and efficacy of selected formulations administered via IV or into the bladders in animal models.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantum Materials and Future Technology
-
批准号:CFREF-2014-00005
-
项目类别:Canada First Research Excellence Fund
-
资助金额:$962.48万
-
财政年份:2021
-
负责人:Burt, Helen
-
依托单位:
Quantum Materials and Future Technologies
-
批准号:10009000009-2017
-
项目类别:Canada First Research Excellence Fund
-
资助金额:$475.1万
-
财政年份:2017
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2012
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2011
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2010
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems composed of amphiphilic block and hyperbranched copolymers
-
批准号:311940-2009
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$1.46万
-
财政年份:2009
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
-
批准号:311940-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.51万
-
财政年份:2007
-
负责人:Burt, Helen
-
依托单位:
Burt Lab/Angiotech Pharmaceuticals partnership
-
批准号:340586-2006
-
项目类别:Synergy Awards
-
资助金额:$1.82万
-
财政年份:2006
-
负责人:Burt, Helen
-
依托单位:
Nanoparticulate drug delivery systems: synthesis and characterization of amphiphilic diblock copolymers
-
批准号:311940-2006
-
项目类别:Discovery Grants Program - Individual
-
资助金额:$2.51万
-
财政年份:2006
-
负责人:Burt, Helen
-
依托单位:
国内基金
海外基金
登录
查看更多内容
酶响应的中性粒细胞外泌体载药体系在眼眶骨缺损修复中的作用及机制研究
-
批准号:82371102
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:苏蕴
-
依托单位:
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
背根神经节中Mrgprd通过一种特异性lncRNA调控阿片类药物耐受的外周机制研究
-
批准号:82371224
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:马柯
-
依托单位:
不同功能基团的电中性Drug-Free纳米颗粒的构建及克服肿瘤耐药的研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:杨胜彩
-
依托单位:
泛素结合酶UBE2S调控GPX4/SLC7A11影响肝癌细胞铁死亡的机制研究
-
批准号:32060159
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2020
-
负责人:莫之婧
-
依托单位:
m6A识别蛋白YTHDF2促白血病细胞生长的研究
-
批准号:32070793
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:赵昀
-
依托单位:
TCF7L2突变介导SMAD7信号轴抑制KRAS突变型结直肠癌转移及耐药的分子机制研究
-
批准号:32000555
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:徐亮
-
依托单位:
PRMT1-meFOXO1通路在低温常压等离子体诱导的三阴型乳腺癌细胞铁死亡中的作用机制研究
-
批准号:31900528
-
项目类别:青年科学基金项目
-
资助金额:19.0万元
-
批准年份:2019
-
负责人:王真
-
依托单位:
Drug-ADR-Pathway复合网络构建及ADR分子机制研究
-
批准号:61372188
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:陈秀杰
-
依托单位:
IL-6自主分泌介导的B细胞来源淋巴造血系统肿瘤耐药的相关机制研究
-
批准号:81172109
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2011
-
负责人:柳凤亭
-
依托单位: